Accession Number: | 0001127602-21-012790 |
Date: | 2021-02-01 |
Issuer: | CVS HEALTH CORP (CVS) |
Original Submission Date: |
MORIARTY THOMAS M
ONE CVS DRIVE
WOONSOCKET, RI 02895
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-02-01 | A | 124,048 | a | $0.00 | 124,048 | direct | ||
COMMON STOCK | 2021-04-01 | F | 61,095 | d | $74.30 | 62,953 | direct | ||
COMMON STOCK | 2021-04-01 | F | 2,350 | d | $74.30 | 65,373 | direct | ||
COMMON STOCK | 2021-02-01 | 0 | $0.00 | 18,226 | indirect | ||||
COMMON STOCK (RESTRICTED) | 2021-02-01 | 0 | $0.00 | 8,008 | direct | ||||
STOCK UNIT | 2021-02-01 | 0 | $0.00 | 45,455 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION | 74.3 | 2021-04-01 | deemed execution date | A | 155,495 (a) | 2022-04-01 | 2031-04-01 | common stock 155,495 | $74.30 | 155,495 | direct | |
STOCK OPTION | 102.26 | 2021-02-01 | deemed execution date | 0 ( ) | 2016-04-01 | 2022-04-01 | common stock 51,361 | $102.26 | 51,361 | direct | ||
STOCK OPTION | 104.82 | 2021-02-01 | deemed execution date | 0 ( ) | 2017-04-01 | 2023-04-01 | common stock 71,696 | $104.82 | 71,696 | direct | ||
STOCK OPTION | 78.05 | 2021-02-01 | deemed execution date | 0 ( ) | 2018-04-03 | 2024-04-03 | common stock 125,224 | $78.05 | 125,224 | direct | ||
STOCK OPTION | 62.21 | 2021-02-01 | deemed execution date | 0 ( ) | 2019-04-01 | 2025-04-01 | common stock 145,959 | $62.21 | 145,959 | direct | ||
STOCK OPTION | 54.19 | 2021-02-01 | deemed execution date | 0 ( ) | 2020-04-01 | 2029-04-01 | common stock 202,007 | $54.19 | 202,007 | direct | ||
STOCK OPTION | 58.34 | 2021-02-01 | deemed execution date | 0 ( ) | 2021-04-01 | 2030-04-01 | common stock 197,116 | $58.34 | 197,116 | direct |
ID | footnote |
---|---|
f1 | represents shares earned by the reporting person pursuant to certain performance stock units (the "psus"), which were granted to the reporting person under the issuer's 2017 incentive compensation plan on february 1, 2021. the psus were earned based on the attainment of certain performance metrics, which performance metrics were certified by the management and planning committee of the board of directors of the issuer on february 1, 2021. the psus vested and settled on april 1, 2021. |
f2 | surrender of shares in payment of taxes due upon the vesting and settlement of the psus on april 1, 2021. |
f3 | surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on april 1, 2021. |
f4 | option becomes exercisable in four equal installments, commencing 4/1/2022. |
f5 | option became exercisable in four equal annual installments, commencing 4/1/2016. |
f6 | option became exercisable in four equal annual installments, commencing 4/1/2017. |
f7 | option became exercisable in four equal annual installments, commencing 4/3/2018. |
f8 | option became exercisable in four equal annual installments, commencing 4/1/2019. |
f9 | option became exercisable in four equal annual installments, commencing 4/1/2020. |
f10 | the number of shares subject to the option were calculated using a 30-day average price. |
f11 | option becomes exercisable in four equal annual installments, commencing 4/1/2021. |